Literature DB >> 573678

Cirrhosis and hypergammaglobulinemia.

J D Stobo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 573678     DOI： 10.1007/bf01317204

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  25 in total

1.  Immunologic response to tetanus toxoid inoculation in patients with hepatic cirrhosis.

Authors:  G R CHERRICK; L POTHIER; J J DUFOUR; S SHERLOCK
Journal:  N Engl J Med       Date:  1959-08-13       Impact factor: 91.245

2.  Relation of splenic and lymph node changes to hypergammaglobulinemia in cirrhosis.

Authors:  S GLAGOV; G KENT; H POPPER
Journal:  AMA Arch Pathol       Date:  1959-01

3.  The production of antibody by patients with chronic hepatic disease.

Authors:  W P HAVENS; J M SHAFFER; C J HOPKE
Journal:  J Immunol       Date:  1951-10       Impact factor: 5.422

4.  Antibodies to intestinal microbes in serum of patients with cirrhosis of the liver.

Authors:  M Bjorneboe; H Prytz; F Orskov
Journal:  Lancet       Date:  1972-01-08       Impact factor: 79.321

5.  Bacterial and dietary antibodies in liver disease.

Authors:  D R Triger; M H Alp; R Wright
Journal:  Lancet       Date:  1972-01-08       Impact factor: 79.321

6.  Immunoglobulins in chronic liver disease.

Authors:  T Feizi
Journal:  Gut       Date:  1968-04       Impact factor: 23.059

7.  Tetanus antitoxin production and gamma globulin levels in patients with cirrhosis of the liver.

Authors:  M Bjorneboe; K B Jensen; I Scheibel; A C Thomsen; M W Bentzon
Journal:  Acta Med Scand       Date:  1970-12

Review 8.  T cell-dependent suppression of an anti-hapten antibody response.

Authors:  A Basten; J F Miller; P Johnson
Journal:  Transplant Rev       Date:  1975

9.  Hepatic suppression of sensitization to antigen absorbed into the portal system.

Authors:  H M Cantor; A E Dumont
Journal:  Nature       Date:  1967-08-12       Impact factor: 49.962

10.  Immunofluorescence studies of anti-T cell antibodies and T cells in systemic lupus erythematosus. Selective loss of brightly staining T cells in active disease.

Authors:  A D Steinberg; L W Klassen; D R Budman; G W Williams
Journal:  Arthritis Rheum       Date:  1979-02
View more
  7 in total

1.  Polyclonal B cell activation in alcoholic patients with no evidence of liver dysfunction.

Authors:  P A Drew; P M Clifton; J T LaBrooy; D J Shearman
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

2.  Detection of monomeric and polymeric IgA containing immune complexes in serum and kidney from patients with alcoholic liver disease.

Authors:  J Sancho; J Egido; M Sánchez-Crespo; R Blasco
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

3.  Demonstration of non-specific B-cell stimulation in patients with cirrhosis.

Authors:  G Holdstock; W B Ershler; E L Krawitt
Journal:  Gut       Date:  1982-09       Impact factor: 23.059

4.  Effect of mesentericocaval shunt upon globulin levels in the rat.

Authors:  G H Engelbrecht; R van Hoorn-Hickman; M Keraan; O L Meyers
Journal:  Dig Dis Sci       Date:  1981-12       Impact factor: 3.199

5.  The injured liver induces hyperimmunoglobulinemia by failing to dispose of antigens and endotoxins in the portal system.

Authors:  Wen Ting Liu; Ying Ying Jing; Zhi Peng Han; Xiao Ning Li; Yan Liu; Fo Bao Lai; Rong Li; Qiu-Dong Zhao; Meng-Chao Wu; Li-Xin Wei
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

6.  Telbivudine on IgG-associated hypergammaglobulinemia and TGF-β1 hyperactivity in hepatitis B virus-related liver cirrhosis.

Authors:  Cheng-Hsun Ho; Ting-Tsung Chang; Rong-Nan Chien
Journal:  PLoS One       Date:  2019-11-26       Impact factor: 3.240

7.  Association of different types of liver disease with demographic and clinical factors.

Authors:  Kao-Chi Cheng; Wen-Yuan Lin; Chiu-Shong Liu; Cheng-Chieh Lin; Hsueh-Chou Lai; Shih-Wei Lai
Journal:  Biomedicine (Taipei)       Date:  2016-08-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.